Home › Trial NCT00004251
Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer
- Trial IDNCT00004251
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorNCIC Clinical Trials Group
- Enrollment33
- Start date2000-01-19
- ConditionsEndometrial Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.